| scholarly article | Q13442814 |
| P2093 | author name string | Mark S Soloway | |
| Vinata B Lokeshwar | |||
| Robert C Duncan | |||
| Pablo Gomez | |||
| Francisco Civantos | |||
| Bal L Lokeshwar | |||
| Yohei Omori | |||
| Brian L Cohen | |||
| P2860 | cites work | Differential expression of thromboxane synthase in prostate carcinoma: role in tumor cell motility | Q34649327 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 1082-1087 | |
| P577 | publication date | 2006-09-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Cyclooxygenase-2 (COX-2) expression is an independent predictor of prostate cancer recurrence | |
| P478 | volume | 119 |
| Q39078279 | A positive feedback loop between STAT3 and cyclooxygenase-2 gene may contribute to Helicobacter pylori-associated human gastric tumorigenesis |
| Q24631043 | ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome |
| Q34525515 | Association of the innate immunity and inflammation pathway with advanced prostate cancer risk |
| Q31130013 | COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial |
| Q28217972 | COX2 genetic variation, NSAIDs, and advanced prostate cancer risk |
| Q36527068 | Characterization of Cyclooxygenase-2 and its induction pathways in response to high lipid diet-induced inflammation in Larmichthys crocea |
| Q28534382 | Combined inhibition of epidermal growth factor receptor and cyclooxygenase-2 leads to greater anti-tumor activity of docetaxel in advanced prostate cancer |
| Q40023730 | Down-regulation of androgen-receptor and PSA by phytochemicals |
| Q39201618 | Evaluation of naproxen and cromolyn activities against cancer cells viability, proliferation, apoptosis, p53 and gene expression of survivin and caspase-3. |
| Q34982560 | Evidence for field cancerization of the prostate |
| Q37316105 | Inflammation and cancer: how friendly is the relationship for cancer patients? |
| Q37025056 | Inflammation and prostate cancer: a future target for prevention and therapy? |
| Q38762796 | Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients |
| Q42574095 | Inhibition of prostaglandin synthesis and actions contributes to the beneficial effects of calcitriol in prostate cancer |
| Q40117008 | Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers |
| Q42971545 | Lack of Association between COX-2 Staining Level and Biochemical Recurrence Following Salvage Radiation Therapy for Recurrent Prostate Cancer |
| Q34142846 | Mechanisms of the Anti-Cancer and Anti-Inflammatory Actions of Vitamin D |
| Q36734036 | New players for advanced prostate cancer and the rationalisation of insulin-sensitising medication |
| Q37155271 | Non-Steroidal Anti-Inflammatory Drugs, Variation in Inflammatory Genes, and Aggressive Prostate Cancer |
| Q38998679 | Odontogenic epithelial proliferation is correlated with COX-2 expression in dentigerous cyst and ameloblastoma |
| Q37882512 | Old issues and new perspectives on prostate cancer hormonal therapy: the molecular substratum |
| Q38425912 | Osteopontin and interleukin-8 expression is independently associated with prostate cancer recurrence |
| Q41831958 | Prediction of prostate cancer recurrence using magnetic resonance imaging and molecular profiles |
| Q38113933 | Radiolabeled COX-2 inhibitors for non-invasive visualization of COX-2 expression and activity--a critical update |
| Q33957249 | Regulation of bombesin-stimulated cyclooxygenase-2 expression in prostate cancer cells |
| Q37202773 | Role of the prostaglandin pathway and the use of NSAIDs in genitourinary malignancies |
| Q39063862 | Saturated fatty acids up-regulate COX-2 expression in prostate epithelial cells via toll-like receptor 4/NF-κB signaling |
| Q30497364 | Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer |
| Q36064572 | Systems analysis of the prostate transcriptome in African-American men compared with European-American men. |
| Q35188826 | The anti-cancer and anti-inflammatory actions of 1,25(OH)₂D₃ |
| Q80652828 | [Prognosis and predictive factors of prostate cancer in the prostatic biopsy] |
| Q45262425 | p53 and cyclooxygenase-2 expression are directly associated with cyclin D1 expression in radical prostatectomy specimens of patients with hormone-naïve prostate cancer |
Search more.